Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can vibration therapy help COPD patients breathe easier?

NCT ID NCT07509606

Knowledge-focused Sponsor: National Cheng Kung University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how different frequencies of whole body vibration affect lung function, breathing muscles, arm strength, flexibility, and quality of life in healthy adults and people with moderate to severe COPD. About 102 participants will try three vibration frequencies in random order, with a week break in between. The goal is to find the best vibration dose to help COPD patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
whole body vibration
What this could lead to
If successful, this could help determine the best vibration frequency to improve breathing, strength, and daily life for people with COPD.
What could go wrong
This is a small, early-stage study looking at immediate effects only. Results may not lead to a proven treatment, and benefits may not last or apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 102 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Healthy individuals Inclusion Criteria: * No prior experience with whole-body vibration therapy or exposure to vibration-related occupations or sports. * Aged between 18 and 65 years. Exclusion Criteria: * Pregnancy. * Acute thrombosis. * Severe cardiovascular disease. * Presence of a cardiac pacemaker. * Recent wounds due to injury or surgery. * Hip or knee implants. * Acute hernia, intervertebral disc degeneration, or spondylolysis. * Severe diabetes mellitus. * Epilepsy. * Recent infection. * Severe migraine. * Tumor. * Recently implanted intrauterine device, metal pins, or metal plates. * Kidney stones. * Organ failure. * Presence of musculoskeletal, respiratory, neurological, cardiovascular conditions, or any form of acute or chronic pain. * Participation in other research studies concurrently. * Regular exercise habits (engaging in moderate-intensity exercise ≥3 times per week). COPD Inclusion Criteria: * Clinically diagnosed with chronic obstructive pulmonary disease (COPD) and classified as Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II, III, or IV. * No history of hospitalization within the past two months. * No participation in any rehabilitation program within the past two months. * Able to comply with the exercise training program. * Aged 18 years or older. Exclusion Criteria: * Severe respiratory diseases (e.g., bronchiectasis, pulmonary fibrosis, asthma, or tuberculosis). * Current smokers. * Hip or knee implants. * Severe joint disease or history of lower extremity surgery. * History of vitreous hemorrhage. * Dependence on supplemental oxygen. * Severe alcohol abuse (\>80 g/day). * Severe malnutrition (BMI \< 19 kg/m²). * Pregnancy. * Acute thrombosis. * Presence of a cardiac pacemaker. * Recent wounds due to injury or surgery. * Acute hernia, intervertebral disc degeneration, or spondylolysis. * Severe diabetes mellitus. * Epilepsy. * Recent infection. * Severe migraine. * Tumor. * Recently implanted intrauterine device, metal pins, or metal plates. * Kidney stones. * Organ failure. * Altered consciousness or inability to comply with assessments. * Participation in other research studies concurrently

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease (COPD) Whole-body vibration

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, 701, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.